SC
Sarath Chandran Sreedharan Nambikeriyil
Director Director DIN 08236118
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Sep 2018
Shareholding value β’β’β’β’ Premium profile
About Sarath Chandran Sreedharan Nambikeriyil
Data last updated:
Sarath Chandran Sreedharan Nambikeriyil was a Director at Max Briston Pharmaceutical Private Limited (2018–2021). The company operates in Pharma.
DIN 08236118
Primary Designation Director
Industry Pharma
First Appointment 24 Sep 2018
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Sep 2018 | 2015 | ₹5.6 Lakh (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Max Briston Pharmaceutical Private Limited
Premium access
Shareholding and investment profile for Sarath Chandran Sreedharan Nambikeriyil
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sarath Chandran Sreedharan Nambikeriyil
Sarath Chandran Sreedharan Nambikeriyil was first appointed on 24 Sep 2018 as Director at Max Briston Pharmaceutical Private Limited.
Sarath Chandran Sreedharan Nambikeriyil held 1 earlier board appointment: Max Briston Pharmaceutical Private Limited (Director, 24 Sep 2018 to 05 Apr 2021).